I also have a position in PRRO, which is definitely a speccie, but this one is different - it's on the market NOW. And with huge cashflow potential - I suspect that many still look on it as a biotech speccie.
Not any more - it's graduated.
HTX Price at posting:
14.0¢ Sentiment: LT Buy Disclosure: Held